Clover Biopharmaceuticals Raises $230 Million in Oversubscribed Series C Financing

[In The News]

Series C financing brings total capital raised in the last 12 months to over US$ 400 million (>RMB 2.5 billion) The proceeds will support the continued development and expansion of Clover's pipeline of protein-based vaccines and biologic cancer therapies CHENGDU, China, Feb. 22, 2021...

View the full article